Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers. —> Read More
The District of Columbia’s needle exchange program prevented 120 new cases of HIV infection and saved an estimated $44 million over just a two-year period, according to a first-of-a-kind study published today by researchers at the Milken Institute School of Public Health at the George Washington University. —> Read More
Children with broken bones or joint dislocations in northern Israel emergency departments received equal pain treatment, regardless of their ethnicity or the ethnicity of the nurses who treated them, even during a period of armed conflict between the two ethnic groups. An investigation of potential disparities in pediatric emergency department pain relief in northern Israel was published online today in Annals of Emergency Medicine. —> Read More
An overgrown sheep dubbed Chris, found wandering near Australia’s capital, sets an unofficial world record for the heaviest fleece. —> Read More
Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a new study. —> Read More
New research may help explain why drug treatments for addiction and depression don’t work for some patients. The conditions are linked to reward and aversion responses in the brain. And the research suggests that some treatments simultaneously stimulate reward and aversion responses, resulting in a net zero effect. —> Read More
Watershed health and water quality issues are a growing concern. Researchers examined the sediments traveling downstream toward Lake Winnipeg using a technique called color fingerprinting. The color of a particular sediment is key to identifying the specific origin of the erosion. —> Read More
Illinois Governor Bruce Rauner partially vetoed the Heroin Crisis Act, which would have cleared the way for Medicaid to fund addiction treatments.
Kim and Kanye have the right idea: Experts say giving your child a unique name can make them more creative
A number of experts claim that a unique name can impact a child’s personality, causing them to think of themselves as special, daring and unconventional. —> Read More
In the New York Times yesterday, psychologist Lisa Feldman Barrett argues that “Psychology is Not in Crisis.” She is responding to the results of a large-scale initiative called the Reproducibility Project, published in Science magazine, which appeared to show that the findings from over 60 percent of a sample of 100 psychology studies did not hold up when independent labs attempted to replicate them.
She argues that “the failure to replicate is not a cause for alarm; in fact, it is a normal part of how science works.” To illustrate this point, she gives us the following scenario:
Suppose you have two well-designed, carefully run studies, A and B, that investigate the same phenomenon. They perform what appear to be identical experiments, and yet they reach opposite conclusions. Study A produces the predicted phenomenon, whereas Study B does not. We have a failure to replicate.
Does this mean that the phenomenon in question is necessarily illusory? Absolutely not. If the studies were well designed and executed, it is more likely that the phenomenon from Study A is true only under certain conditions. The scientist’s job now is to figure out what those conditions are, in order to form new and better hypotheses to test.
She’s making a pretty big assumption here, which is that the studies we’re interested in are “well-designed” and “carefully run.” But a major reason for the so-called “crisis” in psychology — and I’ll come back to the question of just what kind of crisis we’re really talking about (see my title) — is the fact that a very large number of not-well-designed, and not-carefully-run studies have been making it through peer review for decades.